Research Article
Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases
Table 4
Comparison of organ involvement in patients with connective tissue diseases.
| | Parameters (, %) | Groups | values | Overall | | All | Group A: Ro52 alone | Group B: Ro60 alone | Group C: Ro60 and Ro52 | Group A vs. group B | Group A vs. group C | Group B vs. group C |
| | Musculoskeletal | 567 (43.0) | 82 (48.5) | 177 (62.5) | 308 (35.5) | 0.004 | 0.001 | <0.0001 | <0.0001 | | Hematological | 534 (40.5) | 50 (29.6) | 115 (40.6) | 369 (42.6) | 0.018 | 0.002 | 0.569 | 0.007 | | Mucocutaneous | 415 (31.5) | 43 (25.4) | 128 (45.2) | 244 (28.1) | <0.0001 | 0.473 | <0.0001 | <0.0001 | | Glandular | 339 (25.7) | 37 (21.9) | 54 (19.1) | 248 (28.6) | 0.471 | 0.074 | 0.002 | 0.003 | | Pulmonary | 344 (26.1) | 76 (45.0) | 68 (24.0) | 200 (23.1) | <0.0001 | <0.0001 | 0.740 | <0.0001 | | Ocular | 337 (25.5) | 37 (21.9) | 58 (20.5) | 242 (27.9) | 0.724 | 0.107 | 0.014 | 0.023 | | Renal | 263 (19.9) | 12 (7.1) | 71 (25.1) | 180 (20.8) | <0.0001 | <0.0001 | 0.126 | <0.0001 | | Cardiovascular | 185 (14.0) | 23 (13.6) | 48 (17.0) | 114 (13.1) | 0.343 | 0.872 | 0.109 | 0.280 | | Gastrointestinal | 77 (5.8) | 7 (4.1) | 20 (7.1) | 50 (5.8) | 0.204 | 0.397 | 0.427 | 0.439 | | Neuropsychiatric | 67 (5.1) | 4 (2.4) | 24 (8.5) | 39(4.5) | 0.009 | 0.204 | 0.011 | 0.007 |
|
|
